中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月8日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2020, Vol. 27 Issue (29): 170-173    
  调查研究 本期目录 | 过刊浏览 | 高级检索 |
我院肿瘤内科患者留置针静脉炎发生现状及危险因素分析
陈玉叶1 郑建盛2 陈丽山1
1.福建省莆田市第一医院肿瘤内科,福建莆田 351100;
2.莆田学院基础医学部,福建莆田 351100
Analysis of the occurrence status and risk factors of indwelling needle phlebitis in patients of oncology department of our hospital
CHEN Yu-ye1 ZHENG Jian-sheng2 CHEN Li-shan1
1. Department of Oncology, the First Hospital of Putian City, Fujian Province, Putian 351100, China; 
2. Department of Basic Medicine, Putian University, Fujian Province, Putian 351100, China
全文: PDF (0 KB)   HTML (35 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解肿瘤内科患者静脉留置针静脉炎发生现状与危险因素。方法 便利抽样选取2019年8~12月我院收治的361 例肿瘤内科患者,采用自制的留置针静脉炎发生现状及其影响因素问卷进行调查。结果 39.1%患者出现静脉炎症状。单因素分析显示,不同留置时间、穿刺部位、化疗药、高渗透压药、强酸强碱药、冲封管液体种类、给药频次患者的静脉炎发生率比较,差异有统计学意义(P<0.05)。多因素分析显示,留置时间较长、穿刺部位为前臂、使用高渗透压药物和给药频次较多是肿瘤内科患者留置针静脉炎发生的危险因素,使用化疗药物是肿瘤内科患者留置针静脉炎发生的保护因素(P<0.05)。结论 肿瘤内科患者留置针静脉炎发生比例较高,与留置时间长、高渗透压药物和多频次输注等因素有关。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 静脉留置针肿瘤内科静脉炎危险因素统计分析    
AbstractObjective To understand the occurrence status and risk factors of indwelling needle phlebitis in patients of oncology department. Methods A total of 361 cases of cancer patients in our hospital from August to December 2019 were selected by convenient sampling, and the self-made questionnaire on the occurrence and influence of indwelling needle phlebitis was used for investigation. Results Altogether 39.1% patients had phlebitis. Single factor analysis showed that there were significant differences in the incidence rates of phlebitis among patients with different retention time, puncture site, chemotherapy drugs, high osmotic pressure drugs, strong acid and strong alkali drugs, types of flushing and sealing fluid, and administration frequency (P<0.05). Multivariate analysis showed that the long duration of indwelling, location of puncture was forearm, use of hypertonic drugs and frequency of drug administration were risk factors of the incidence of phlebitis, and the use of chemotherapeutics was a protective factor for the occurrence of phlebitis caused by indwelling needle in patients with oncology department (P<0.05). Conclusion The incidence of phlebitis is relatively high in the use of indwelling needle in oncology department, which is related to the factors such as long indwelling time, hypertonic and osmotic drugs and multi frequency infusion.
Key wordsIntravenous indwelling needle    Oncology department    Phlebitis    Risk factors    Statistical analysis
收稿日期: 2020-04-17     
引用本文:   
陈玉叶;郑建盛;陈丽山. 我院肿瘤内科患者留置针静脉炎发生现状及危险因素分析[J]. 中国当代医药, 2020, 27(29): 170-173.
CHEN Yu-ye1 ZHENG Jian-sheng2 CHEN Li-shan1. Analysis of the occurrence status and risk factors of indwelling needle phlebitis in patients of oncology department of our hospital. 中国当代医药, 2020, 27(29): 170-173.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2020/V27/I29/170
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载